325 related articles for article (PubMed ID: 1940305)
1. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
[TBL] [Abstract][Full Text] [Related]
2. A high resolution ultrastructural study of experimental murine AA amyloid.
Inoue S; Kisilevsky R
Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
[TBL] [Abstract][Full Text] [Related]
3. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.
Snow AD; Willmer J; Kisilevsky R
Lab Invest; 1987 Dec; 57(6):687-98. PubMed ID: 2447384
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
6. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
Moss J; Shore I; Woodrow D
Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
[TBL] [Abstract][Full Text] [Related]
7. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
Snow AD; Kisilevsky R; Stephens C; Anastassiades T
Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
[TBL] [Abstract][Full Text] [Related]
10. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
Niewold TA; Flores Landeira JM; van den Heuvel LP; Ultee A; Tooten PC; Veerkamp JH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):321-8. PubMed ID: 1685039
[TBL] [Abstract][Full Text] [Related]
11. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
Stenstad T; Magnus JH; Husby G
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
[TBL] [Abstract][Full Text] [Related]
13. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
[TBL] [Abstract][Full Text] [Related]
14. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
15. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Ailles L; Kisilevsky R; Young ID
Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.
Westermark GT; Norling B; Westermark P
Clin Exp Immunol; 1991 Oct; 86(1):150-6. PubMed ID: 1914228
[TBL] [Abstract][Full Text] [Related]
17. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
Inoue S; Hultin PG; Szarek WA; Kisilevsky R
Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
[TBL] [Abstract][Full Text] [Related]
18. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.
Nelson SR; Lyon M; Gallagher JT; Johnson EA; Pepys MB
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):67-73. PubMed ID: 1902087
[TBL] [Abstract][Full Text] [Related]
20. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
Inoue S; Kawano H; Ishihara T; Maeda S; Ohno S
Amyloid; 2005 Sep; 12(3):157-63. PubMed ID: 16194870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
